AU2003245448A1 - Cancer-linked gene as target for chemotherapy - Google Patents
Cancer-linked gene as target for chemotherapyInfo
- Publication number
- AU2003245448A1 AU2003245448A1 AU2003245448A AU2003245448A AU2003245448A1 AU 2003245448 A1 AU2003245448 A1 AU 2003245448A1 AU 2003245448 A AU2003245448 A AU 2003245448A AU 2003245448 A AU2003245448 A AU 2003245448A AU 2003245448 A1 AU2003245448 A1 AU 2003245448A1
- Authority
- AU
- Australia
- Prior art keywords
- chemotherapy
- cancer
- target
- linked gene
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 238000002512 chemotherapy Methods 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38867202P | 2002-06-13 | 2002-06-13 | |
US60/388,672 | 2002-06-13 | ||
US39796602P | 2002-07-23 | 2002-07-23 | |
US60/397,966 | 2002-07-23 | ||
PCT/US2003/018431 WO2003106624A2 (en) | 2002-06-13 | 2003-06-11 | Cancer-linked gene as target for chemotherapy |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003245448A1 true AU2003245448A1 (en) | 2003-12-31 |
AU2003245448A8 AU2003245448A8 (en) | 2003-12-31 |
Family
ID=29740051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003245448A Abandoned AU2003245448A1 (en) | 2002-06-13 | 2003-06-11 | Cancer-linked gene as target for chemotherapy |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003245448A1 (en) |
WO (1) | WO2003106624A2 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5876996A (en) * | 1997-07-25 | 1999-03-02 | Incyte Pharmaceuticals, Inc. | Human S-adenosyl-L-methionine methyltransferase |
-
2003
- 2003-06-11 AU AU2003245448A patent/AU2003245448A1/en not_active Abandoned
- 2003-06-11 WO PCT/US2003/018431 patent/WO2003106624A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003106624A2 (en) | 2003-12-24 |
WO2003106624A3 (en) | 2004-12-09 |
AU2003245448A8 (en) | 2003-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003245441A1 (en) | Cancer-linked gene as target for chemotherapy | |
AU2003229294A1 (en) | Cancer-linked gene as target for chemotherapy | |
EP1575492A3 (en) | Cancer-linked gene as target for chemotherapy | |
AU2003249691A1 (en) | Cancer-linked gene as target for chemotherapy | |
EP1576111A3 (en) | Cancer-linked gene as target for chemotherapy | |
AU2003239969A1 (en) | Cancer-linked gene as target for chemotherapy | |
AU2003253677A1 (en) | Cancer-linked gene as target for chemotherapy | |
AU2003213743A1 (en) | Cancer-linked gene as target for chemotherapy | |
AU2003238897A1 (en) | Cancer-linked gene as target for chemotherapy | |
AU2003229293A1 (en) | Cancer-linked gene as target for chemotherapy | |
AU2003237414A1 (en) | Cancer-linked gene as target for chemotherapy | |
AU2003230611A1 (en) | Cancer-linked gene as target for chemotherapy | |
AU2003247564A1 (en) | Cancer-linked gene as target for chemotherapy | |
AU2003218014A1 (en) | Cancer-linked gene as target for chemotherapy | |
AU2003243440A1 (en) | Cancer-linked gene as target for chemotherapy | |
AU2003241456A1 (en) | Cancer-linked gene as target for chemotherapy | |
AU2003213672A1 (en) | Cancer-linked gene as target for chemotherapy | |
AU2003245536A1 (en) | Cancer-linked gene as target for chemotherapy | |
AU2003248528A1 (en) | Cancer-linked gene as target for chemotherapy | |
AU2003276643A1 (en) | Cancer-linked gene as target for chemotherapy | |
AU2003251515A1 (en) | Cancer-linked gene as target for chemotherapy | |
AU2003245448A1 (en) | Cancer-linked gene as target for chemotherapy | |
AU2003240572A1 (en) | Cancer-linked gene as target for chemotherapy | |
AU2003241455A1 (en) | Cancer-linked gene as target for chemotherapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |